Postoperative radiotherapy in perivascular epithelioid cell tumors (PEComas): A narrative review

Abstract

Perivascular epithelioid cell tumor (PEComa), which is relatively new to the literature, is a rare mesenchymal tumor containing perivascular epithelioid cells. The immunohistochemical features of the disease must be considered for diagnosis. The disease contains melanocytic differentiation markers such as HMB45 and MelanA/Mart1, and myogenic markers such as actin, but does not express markers such as epithelial membrane antigen, keratin, or S-100. The disease can be seen in almost every organ. Most PEComas are benign. Malignant PEComa can follow an aggressive course, capable of recurrence and metastasis. The primary treatment approach for localized disease is surgical resection. Adjuvant systemic therapy can be administered to high-risk patients. It is noteworthy that the literature on postoperative radiotherapy in PEComa is limited with studies focusing primarily on gynecological cases. Most of the patients remained disease-free during follow-up, suggesting radiotherapy may be effective for local control. Integration of molecular profiling and mTOR-targeted approaches alongside radiotherapy may further define optimal management strategies.

Keywords

• PEComa
• Rare Tumor
• Postoperative Radiotherapy
• Local Control
• mTOR inhibitors.

References

1. Pea M, Martignoni G, Zamboni G, et al. Perivascular epithelioid cell. Am J Surg Pathol 1996;20:1149-53. doi: 10.1097/00000478-199609000-00012
2. Zamboni G, Pea M, Martignoni G, et al. Clear cell “sugar” tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol 1995:20: 722-30. doi: 10.1097/00000.478.199606000-00010.
3. Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology 2006;48:75-82. doi: 10.1111/j.1365- 2559.2005.02316.x.
4. Thway K, Fisher C. PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 2015;19:359-68. doi: 10.1016/j.anndiagpath.2015.06.003.
5. Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch 2008 ;452:119-32. doi: 10.1007/s00428-007-0509-1.
6. Chen Z, Zheng X, Lin Q. A case report and literature review: leiomyosarcoma or perivascular epithelioid cell neoplasm? Front Oncol. 2024:20:14:1499403. doi: 10.3389/fonc.2024.1499403.
7. Bonetti F, Martignoni G, Colato C, et al. Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis. Mod Pathol 2001;14:563-8. doi: 10.1038/modpathol.3880351.
8. Panizo-Santos A, Sola I, de Alava E, et al. Angiomyolipoma and PEComa are immunoreactive for MyoD1 in cell cytoplasmic staining pattern. Appl Immunohistochem Mol Morphol 2003;11:156-60. ddoi: 10.1097/00129039-200306000-00012.

9. Fadare O, Parkash V, Yilmaz Y, et al. Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal “PEComatosis”: A clinicopathological study with comparative genomic hybridization analysis. World J Surg Oncol 2004;2:35. doi: 10.1186/1477-7819-2-35.
10. Caliskan S, Akar OS, Gun S, Kefeli M. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus as part of the hereditary cancer syndrome: A case diagnosed with multiple malignancies. Turk Patoloji Derg 2023;39:212-7. doi: 10.5146/ tjpath.2022.01592.
11. Stuart LN, Tipton RG, DeWall MR, et al. Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature. J Cutan Pathol 2017;44:713-21. doi: 10.1111/cup.12972.
12. Rehman R, Aoun M, Levitin R, Quinn T, Kabolizadeh P. Perivascular epithelioid cell tumor of the buttock region. Cureus 2021; 13: e15252. doi: 10.7759/cureus.15252.
13. Lau SK. Malignant PEComa of the adrenal gland. Pathol Res Pract 2012;208:113-7. doi: 10.1016/j.prp.2011.11.002.
14. Pant L, Kalita D, Chopra R, et al. Malignant perivascular epithelioid cell tumor (PEComa) of the adrenal gland: report of a rare case posing diagnostic challenge with the role of ımmunohistochemistry in the diagnosis. Endocr Pathol.2015;26:129-34. doi: 10.1007/s12022-015-9360-0.
15. Martignoni G, Pea M, Zampini C, et al. PEComas of the kidney and of the genitourinary tract. Semin Diagn Pathol 2015;32:140-59. doi: 10.1053/j.semdp.2015.02.006.
16. Baek JH, Chung MG, Jung DH, et al. Perivascular epithelioid cell tumor (PEComa) in the transverse colon of an adolescent: a case report. Tumori 2007;93:106-8. doi: 10.1177/030089160709300120.
17. Gross E, Vernea F, Weintraub M, Koplewitz BZ. Perivascular epithelioid cell tumor of the ascending colon mesentery in a child: case report and review of the literature. J Pediatr Surg 2010;45:830-3. doi: 10.1016/j.jpedsurg.2010.01.015.
18. Huang Y, Lu G, Quan J, et al. Primary perivascular epithelioid cell tumor of the bladder. Ann Diagn Pathol. 2011 Dec;15(6):427-30. doi: 10.1016/j.anndiagpath.2010.07.006.
19. Zhao L, Anders KH. Malignant perivascular epithelioid cell tumor of the gallbladder: a case report and review of literature. Arch Pathol Lab Med 2014;138:1238-41. doi: 10.5858/ arpa.2013-0092-CR.
20. Natella V, Merolla F, Giampaolino P, Bifulco G, Mainenti PP, Insabato L. A huge malignant perivascular epithelioid cell tumor (PEComa) of the uterine cervix and vagina. Pathol Res Pract 2014;210:186-8. doi: 10.1016/j.prp.2013.10.003.
21. Singer E, Yau S, Johnson M. Retroperitoneal PEComa: Case report and review of literature. Urol Case Rep 2018; 19: 9-10. doi: 10.1016/j.eucr.2018.03.012.
22. Akay SU, Kesen O, Küçük D, Yener E. Adrenal PEComa treated by surgical resection and postoperative radiotherapy: A case report. Am J Case Rep 2024:25:e945177. doi: 10.12659/ AJCR.945177.
23. Patra S, Vij M, Kota V, Kancherla R, Rela M. Pigmented perivascular epithelioid cell tumor of the liver: report of a rare case with brief review of literature. J Cancer Res Ther 2013;9:305-7. doi: 10.4103/0973-1482.113401.
24. Lian DWQ, Chuah KL, Cheng MHW, Yap W. Malignant perivascular epithelioid cell tumour of the fibula: a report and a short review of bone perivascular epithelioid cell tumour. J Clin Pathol 2008;61:1127-9. doi: 10.1136/jcp.2008.060137.
25. Bleeker JS, Quevedo JF, Folpe AL. “Malignant” perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma 2012;2012:541626. doi: 10.1155/2012/541626.
26. Bourgmayer A, Nannini S, Bonjean P, Kurtz JE, Malouf GG, Gantzer J. Natural history and treatment strategies of advanced PEComas: A systematic review. Cancers (Basel) 2021;13:5227. doi: 10.3390/cancers13205227.
27. Jeon IS, Lee SM. Multimodal treatment using surgery, radiotherapy, and chemotherapy in a patient with a perivascular epithelioid cell tumor of the uterus. J Pediatr Hematol Oncol 2005;27:681-4. doi: 10.1097/01.mph.0000193475.06870.d5.
28. Tazelaar HD, Batts KP, Srigley JR. Primary extrapulmonary sugar tumor(PEST): a report of four cases. Mod Pathol 2001;14:615–622. doi: 10.1038/modpathol.3880360.
29. Starbuck KD, Drake RD, Budd GT, Rose PG. Treatment of advanced malignant uterine perivascular epithelioid cell tumor with mTOR inhibitors: Single-institution experience and review of the literature. Anticancer Res 2016 ;36:6161-4. doi: 10.21873/anticanres.11208.
30. Wagner AJ, Malinowska-Kolodziej I, Morgan JA, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol 2010;28:835- 40. doi: 10.1200/JCO.2009.25.2981.
31. Fukunaga M. Perivascular epithelioid cell tumor of the uterus: report of four cases. Int J Gynecol Pathol 2005 ;24:341-6. doi: 10.1097/01.pgp.0000168515.83557.89
32. Folpe AL, Mentzel T, Lehr HA, eFisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 2005;29:1558-75. doi: 10.1097/01.pas.000.017.3232.22117.37.
33. Vang R, Kempson RL. Perivascular epithelioid cell tumor (‘PEComa’) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 2002;26:1-13. doi: 10.1097/00000478-200201000-00001.
34. Fink D, Marsden DE, Edwards L, Camaris C, Hacker NF. Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligament. Int J Gynecol Cancer 2004;14:1036-9. doi: 10.1111/j.1048-891X.2004.014549.x.
35. Bradshaw MJ, Folpe AL, Croghan GA. Perivascular epithelioid cell neoplasm of the uterine cervix: an unusual tumor in an unusual location. Rare Tumors. 2010;2:e56. doi: 10.4081/ rt.2010.e56.
36. Liu CH, Chao WT, Lin SC, Lau HY, Wu HH, Wang PH. Malignant perivascular epithelioid cell tumor in the female genital tract: Preferred reporting items for systematic reviews and meta-analyses. Medicine (Baltimore) 2019;98:e14072. ddoi: 10.1097/MD.0000000000014072.
37. Su YC, Lee WC, Wang CC, et al. Targeting PI3K/AKT/mTOR signaling pathway as a radiosensitization in head and neck squamous cell carcinomas. Int J Mol Sci 2022;23:15749. doi: 10.3390/ijms232415749.
38. Chang L, Graham PH, Ni J, et al. Targeting PI3K/Akt/ mTOR signaling pathway in the treatment of prostate cancer radioresistance. Crit Rev Oncol Hematol 2015;96:507-17. doi: 10.1016/j.critrevonc.2015.07.005.